期刊文献+

研究氨氯地平联合卡托普利治疗冠心病合并高血压的临床治疗效果 被引量:3

下载PDF
导出
摘要 目的:分析针对合并高血压的冠心病患者以氨氯地平、卡托普利联合用药治疗的疗效。方法:收集本科室接收的合并高血压的80例冠心病患者,随机分成两组:参考组共40例,单以氨氯地平用药治疗;治疗组共40例,确诊后接受与参考组相同的用药治疗,同时联合卡托普利用药治疗。观察及比较两组的临床疗效。结果:与参考组开展对照分析发现,治疗组经治疗后的高血压有效率、冠心病有效率均更高,差异显著(P<0.05)。结论:针对合并高血压的冠心病患者以氨氯地平、卡托普利联合用药治疗疗效显著,值得借鉴。
作者 杜丞禹
出处 《影像研究与医学应用》 2017年第12期181-182,共2页 Journal of Imaging Research and Medical Applications
  • 相关文献

参考文献5

二级参考文献55

  • 1王素敏,沈嵘,石小燕,蒋淘,刘小梅,史颖莉,陈盛强,张伟毅.同型半胱氨酸代谢酶基因突变多态性与妊娠高血压综合征遗传易感性研究[J].中国优生与遗传杂志,2006,14(4):15-17. 被引量:22
  • 2Czemichow S, Zanchetti A, Turnbull F , et at. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major car?diovascular events according to baseline blood pressure: meta-analysis of randomized trials(J). J Hypertens ,2011 ;29(1) :4-16.
  • 3Conroy RM, Pyooraalaa K, Fitzgerald AP , et at. Estimation of ten -year risk of fatal cardiovascular disease in Europe: the SCORE project[J] . Eur Heart J ,2003 ;24(11) :987-1003.
  • 4De Backer G, Petrella JR, Goudev AR, et at. Design and methodology of POWER, an open-label observation of the effect of primary care interven- tions on total cardiovascular risk in patients with hypertension[J]. Fun?dam Clin Phannacol,2013;27(2) :210-5.
  • 5Turnbull F. Blood pressure lowering treatment trialists' collaboration. Effects of differentblo,?d-pressure-Iowering regimens on major cardiovas?cular events: results of prospectively designed overviews of randomised trialsj J]. Lancet ,2003 ;362(9395) : 1527 -35.
  • 6Ambrosioni E, Bombelli M, Cerasola G, et al. Ambulatory monitoring of systolic hypertension in the elderly: eprosartanlhydrochlorothiazide com?pared with losartanlhydrochlorothiazide(INSIST trial)[J] . Adv Ther, 2010 ;27(6) :365-80.
  • 7Guallar E, Banegas JR, Blasco-Colmenares E, et at. Excess risk attributa?ble to traditional cardiovascular risk factors in clinical practice settings across Europe The EURIKA Study[J] . BMC Public Health, 2011 ; 11 : 704.
  • 8Xu FY , Yang B, Shi D, et al. Antihypertensive effects and safety of epro?sartan: a meta-analysis of randomized controlled trials[J] . Eur J Clin Phannacol,2012;68(2) :195-205.
  • 9Baumhalikel M, Boohm M. Cardiovascular outcomes with angiotensin II receptor blockers: clinical implications of recent trials[J] . Vase Health Risk Manag,2011 ;7 :391-7.
  • 10Flack JM, Nasser SA. Benefits of once-daily therapies in the treatment of hypertension[1). Vase Health Risk Manag, 20 II ; 7 : 777 -87.

共引文献201

同被引文献19

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部